I+D de fármacos
GI-1606
![Foto de I+D de fármacos](/img/grupo.png)
![Foto de Hospital Alemão Oswaldo Cruz](/img/noimage_org.png)
Hospital Alemão Oswaldo Cruz
São Paulo, BrasilPublicacións en colaboración con investigadores/as de Hospital Alemão Oswaldo Cruz (1)
2024
-
N-(coumarin-3-yl)cinnamamide Promotes Immunomodulatory, Neuroprotective, and Lung Function-Preserving Effects during Severe Malaria
Pharmaceuticals, Vol. 17, Núm. 1